Table 2.
Herbs | Dose | Chemotherapy | Effects | Refs. |
---|---|---|---|---|
Acorus calamus | 100–200 mg/kg | Vincristine in rats | Attenuates symptoms of neuropathy through serotonin 5-HT1A receptors | [28] |
Butea monosperma | 200–400 mg/kg | Vincristine in rats | Reverses alterations of behavioral, biochemical, and histopathological changes | [29] |
Ginkgo biloba L. | 50–150 mg/kg | Vincristine in rats | Decreases paw-withdrawal frequency to cold stimuli and increases the threshold to mechanical stimuli Suppresses NF-κB activation and production of TNF-α and NO Inhibits axonal degradation Improves axonal transportation |
[30] |
100–200 mg/kg | Cisplatin in rats, mice, guinea pigs | Protects the inner ear from ototoxicity | [31] | |
Camellia sinensis | 300 mg/kg | Oxaliplatin in rats | Alleviates mechanical allodynia and thermal hyperalgesia, but does not prevent morphometric or electrophysiological alterations | [32] |
Ocimum sanctum | 100–200 mg/kg | Vincristine in rats | Attenuates neurotoxicity with the decline in calcium levels and oxidative stress | [33] |
Salvia officinalis | 100 mg/kg | Cisplatin in mice, | Suppresses a second phase of cisplatin-enhanced pain in the formalin test | [34] |
Walnut | 6% of diet | Cisplatin in rats | Inhibits an alteration in performance of hippocampus- and cerebellum-related behaviors | [35] |
Xylopia aethiopica | 30–300 mg/kg | Vincristine in rats | Has anti-allodynic and anti-hyperalgesic properties | [27] |